PerfectJR, CasadevallA. Cryptococcosis. Infect Dis Clin North Am, 2002; 16(4):837–874.
2.
ChayakulkeereeM, PerfectJR. Cryptococcosis. Infect Dis Clin North Am, 2006; 20(3):507–544.
3.
PappasPG, PerfectJR, CloudGA, LarsenRA, PankeyGA, LancasterDJ, et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis, 2001; 33(5):690–699.
ChangWC, TzaoC, HsuHH, LeeSC, HuangKL, TungHJ, et al. Pulmonary cryptococcosis: comparison of clinical and radiographic characteristics in immunocompetent and immunocompromised patients. Chest, 2006; 129(2):333–340.
EisenmanHC, CasadevallA, McClellandEE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Respir, 2007; 9(6):457–464.
MitchellDH, SorrellTC. Pancoast's syndrome due to pulmonary infection with Cryptococcus neoformans variety gattii. Clin Infect Dis, 1992; 14(5):1142–1144.
10.
MitsuokaS, KanazawaH. Images in Thorax. An unique case of primary pulmonary cryptococcosis with extensive chest wall invasion. Thorax, 2005; 60(1):86.
11.
BinfordCH, DooleyJR: Diseases caused by fungi and actinomycetes. In: BinfordCH, ConnorDH, editors. Pathology of tropical and extraordinary diseases. Volume 2. Washington DC: Armed Forces Institute of Pathology; 1976:572.
12.
BulmerGS, SansMD. Cryptococcus neoformans II: Phagocytosis by human leukocytes. J Bacteriol, 1967; 94(5):1480–1483.
GutierrezF, FuYS, LurieH. Cryptococcosis histologically resembling histoplasmosis. A light and electron microscopic study. Arch Pathol, 1975; 99(7):347–352.
15.
HardingSA, ScheldWM, FeldmanPS, SandeMA. Pulmonary infection with capsule-deficient Cryptococcus neoformans. Virchows Arch A Pathol Anat Histol, 1979; 382(1):113–118.
16.
ChangYC, PenoyerLA, Kwon-ChungKJ. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun, 1996; 64(6):1977–1983.
17.
CheonWS, EomKS, YooBK, JangSH, BahnJW, KimDG, et al. A case of pulmonary cryptococcosis by capsule-deficient Cryptococcus neoformans. Korean J Intern Med, 2006; 21(1):83–87.
18.
RoyJY, LeeSS, AyalaAG. Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med, 1987; 111(1):53–57.
19.
Kwon-ChungKJ, HillWB, BennettJE. New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol, 1981; 13(2):383–287.
20.
TorresHA, PrietoVG, RaadII, KontoyiannisDP. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact C. neoformans. Mycoses, 2005; 48(1):21–24.
21.
BaddleyJW, PerfectJR, OsterRA, LarsenRA, PankeyGA, HendersonH, et al. Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis, 2008; 27(10):937–943.
22.
SaagMS, GraybillRJ, LarsenRA, PappasPG, PerfectJR, PowderlyWG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Disease Society of America. Clin Infect Dis, 2000; 30(4):710–718.